AU2003232077A8 - Cyclic peptide anti-cancer agents and methods - Google Patents

Cyclic peptide anti-cancer agents and methods

Info

Publication number
AU2003232077A8
AU2003232077A8 AU2003232077A AU2003232077A AU2003232077A8 AU 2003232077 A8 AU2003232077 A8 AU 2003232077A8 AU 2003232077 A AU2003232077 A AU 2003232077A AU 2003232077 A AU2003232077 A AU 2003232077A AU 2003232077 A8 AU2003232077 A8 AU 2003232077A8
Authority
AU
Australia
Prior art keywords
methods
cyclic peptide
cancer agents
peptide anti
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003232077A
Other versions
AU2003232077A1 (en
Inventor
M Reza Ghadiri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of AU2003232077A8 publication Critical patent/AU2003232077A8/en
Publication of AU2003232077A1 publication Critical patent/AU2003232077A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003232077A 2002-05-06 2003-05-06 Cyclic peptide anti-cancer agents and methods Abandoned AU2003232077A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37839502P 2002-05-06 2002-05-06
US60/378,395 2002-05-06
PCT/US2003/014373 WO2003092632A2 (en) 2002-05-06 2003-05-06 Cyclic peptide anti-cancer agents and methods

Publications (2)

Publication Number Publication Date
AU2003232077A8 true AU2003232077A8 (en) 2003-11-17
AU2003232077A1 AU2003232077A1 (en) 2003-11-17

Family

ID=29401603

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003232077A Abandoned AU2003232077A1 (en) 2002-05-06 2003-05-06 Cyclic peptide anti-cancer agents and methods

Country Status (2)

Country Link
AU (1) AU2003232077A1 (en)
WO (1) WO2003092632A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001259837A1 (en) 2000-05-09 2001-11-20 Greenville Hospital System Therapeutic pore-forming peptides
US7456146B2 (en) * 2001-05-09 2008-11-25 Ghc Research Development Corporation Lytic peptide prodrugs
WO2010051667A1 (en) * 2008-11-10 2010-05-14 复旦大学 Pharmaceutical compositions comprising cyclic peptide nanotubes and the uses thereof
ES2342874B2 (en) * 2010-02-19 2011-01-27 Fundacio Privada Institut D'investigacio Biomedica De Girona Dr. Josep Trueta INHIBITING CYCLIC PEPTIDES OF CELLULAR GROWTH.
WO2013025099A1 (en) * 2011-08-17 2013-02-21 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg Substrates for the detection of periopathogens of the oral cavity
WO2014035345A1 (en) * 2012-08-29 2014-03-06 Agency For Science, Technology And Research Peptides and uses thereof
US10092620B2 (en) * 2013-04-02 2018-10-09 The Scripps Research Institute Uses of cyclic peptides for treating and preventing atherosclerosis
US10815276B2 (en) 2014-05-21 2020-10-27 Entrada Therapeutics, Inc. Cell penetrating peptides and methods of making and using thereof
PT3149025T (en) 2014-05-21 2019-08-01 Entrada Therapeutics Inc Cell penetrating peptides and methods of making and using thereof
EP3185880B1 (en) 2014-08-27 2020-02-12 Ohio State Innovation Foundation Improved peptidyl calcineurin inhibitors
CN106699841B (en) * 2017-01-05 2020-07-24 北京大学深圳研究生院 Self-assembled polypeptide nanorod and preparation method thereof
US11576946B2 (en) 2018-01-29 2023-02-14 Ohio State Innovation Foundation Peptidyl inhibitors of calcineurin-NFAT interaction
TW201945014A (en) 2018-02-22 2019-12-01 美商安卓達治療股份有限公司 Compositions and methods for treating Mitochondrial Neurogastrointestinal Encephalopathy
US11987647B2 (en) 2018-05-09 2024-05-21 Ohio State Innovation Foundation Cyclic cell-penetrating peptides with one or more hydrophobic residues

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277818B1 (en) * 1998-10-29 2001-08-21 Angstrom Pharmaceuticals, Inc. Cyclic peptide ligands that target urokinase plasminogen activator receptor
US6096707A (en) * 1997-07-11 2000-08-01 Biotie Therapies Ltd. Integrin binding peptide and use thereof

Also Published As

Publication number Publication date
WO2003092632A2 (en) 2003-11-13
WO2003092632A3 (en) 2007-11-01
AU2003232077A1 (en) 2003-11-17

Similar Documents

Publication Publication Date Title
EP1469860A4 (en) Anti-cancer combination and use thereof
IL172195A0 (en) Thiotungstate analogues and uses thereof
AU2003232077A8 (en) Cyclic peptide anti-cancer agents and methods
AU2003241384A8 (en) Cyclic peptide anti-viral agents and methods
IL165112A0 (en) Variant integrinpolypeptides and thereof
AU2003272423A8 (en) Centrosome proteins and uses thereof
GB0309064D0 (en) Modified peptides and their uses
AU2003207628A8 (en) Structural and cytoskeleton-associated proteins
AU2003247367A8 (en) Stimulation and injection system
HK1209049A1 (en) Survivin-derived peptides and use thereof
EP1487459A4 (en) Peptide analogues and uses thereof
GB0202275D0 (en) Peptide
GB0317376D0 (en) Immunogenic protein and uses thereof
EP1699809A4 (en) Amniotic-derived peptide and uses thereof
GB0223860D0 (en) Polypeptide methods and means
AU2003228397A8 (en) Hausp-p53 interaction and uses thereof
GB0210746D0 (en) Peptide
GB0228538D0 (en) Protein structure and uses thereof
GB0321300D0 (en) Protein structure and uses thereof
TW514001U (en) Clipping and aligning structure
IL149179A0 (en) FcyRII-BINDING PEPTIDES AND USES THEREOF
AU2003303464A8 (en) Centrosome-associated protein and applications thereof
GB0312990D0 (en) Peptides and uses thereof
GB0323193D0 (en) Peptides and uses thereof
AU2003206133A8 (en) Echinocandin cyclic peptide derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase